Patients with advanced-stage or treatment-resistant colorectal cancer (CRC) benefit less
from traditional therapies; hence, new therapeutic strategies may help improve the treatment …

Colorectal cancer (CRC) is a common malignant tumor characterized by unchecked division
and survival of abnormal cells in the colon or rectum with high morbidity and mortality …

Colorectal cancer (CRC) is a common malignant tumor associated with high morbidity and
mortality. Despite an increase in early screening and treatment options, people with CRC …

Colorectal cancer (CRC) is the second deadliest cancer and the third-most common
malignancy in the world. Surgery, chemotherapy, and targeted therapy have been widely …

Ferroptosis is a newly discovered type of cell-regulated death. It is characterized by the
accumulation of iron-dependent lipid peroxidation and can be distinguished from other …

Simple Summary In the realm of colorectal cancer treatment, drug resistance is a formidable
obstacle. However, a ray of hope emerges in the form of ferroptosis, a unique iron-driven cell …

Colorectal cancer (CRC) is the third leading cause of cancer deaths worldwide and is
characterised by frequently mutated genes, such as APC, TP53, KRAS and BRAF. The …

Colorectal cancer (CRC) has been one of the most common cancers and maintains the
second-highest incidence and mortality rates among all cancers. The high risk of recurrence …

Colorectal cancer (CRC) is the third most common malignant tumor in the world. CRC has
high morbidity and mortality rates and it is a serious threat to human health. Ferroptosis is a …

Colorectal cancer (CRC) is the third highest incidence and the second highest mortality
malignant tumor in the world. The etiology and pathogenesis of CRC are complex. Due to …